It is very important to capitalise on innovative developments and implement the latest in-vitro and in-silico models to address the continual challenge of in-vitro and in-vivo extrapolation. In this Pharma IQ interview we are joined by Jorge I. González Borroto, senior toxicologist for pharmacology and safety at Ferrer International.
To continue reading this story Click Here
Upcoming Events
Pharmaceutical Launch Excellence Summit
2 - 3 December, 2025
UK
Register Now |
View Agenda |
Learn More